Atai Life Sciences N.V.
Stock Forecast, Prediction & Price Target
Atai Life Sciences N.V. Financial Estimates
Atai Life Sciences N.V. Revenue Estimates
Atai Life Sciences N.V. EBITDA Estimates
Atai Life Sciences N.V. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $20.37M N/A | $233K -98.85% | $314K 34.76% | Avg: $250K Low: $250K High: $250K avg. -20.38% | Avg: $30.88M Low: $30.88M High: $30.88M avg. 12253.33% | Avg: $192.93M Low: $192.93M High: $192.93M avg. 524.72% | Avg: $504.54M Low: $504.54M High: $504.54M avg. 161.51% |
Net Income
% change YoY
| $-132.61M N/A | $-141.41M -6.63% | $-40.22M 71.55% | Avg: $-139.00M Low: $-133.42M High: $-77.82M avg. -245.57% | Avg: $-124.70M Low: $-155.65M High: $60.35M avg. 10.28% | Avg: $65.91M Low: $65.91M High: $65.91M avg. 152.85% | Avg: $255.72M Low: $255.72M High: $255.72M avg. 287.95% |
EBITDA
% change YoY
| $-104.84M N/A | $-144.07M -37.41% | $-36.31M 74.79% | Avg: $-49.99K Low: $-49.99K High: $-49.99K avg. 99.86% | Avg: $-6.17M Low: $-6.17M High: $-6.17M avg. -12253.57% | Avg: $-38.58M Low: $-38.58M High: $-38.58M avg. -524.72% | Avg: $-100.90M Low: $-100.90M High: $-100.90M avg. -161.51% |
EPS
% change YoY
| -$0.83 N/A | -$0.91 -9.63% | -$0.25 72.52% | Avg: -$0.7 Low: -$0.84 High: -$0.49 avg. -181.33% | Avg: -$0.53 Low: -$0.98 High: $0.38 avg. 24.64% | Avg: $0.42 Low: $0.42 High: $0.42 avg. 178.30% | Avg: $1.61 Low: $1.61 High: $1.61 avg. 287.95% |
Operating Expenses
% change YoY
| $140.70M N/A | $144.66M 2.81% | $125.78M -13.04% | Avg: $25.54M Low: $25.54M High: $25.54M avg. -79.68% | Avg: $3.15B Low: $3.15B High: $3.15B avg. 12253.33% | Avg: $19.71B Low: $19.71B High: $19.71B avg. 524.72% | Avg: $51.56B Low: $51.56B High: $51.56B avg. 161.51% |
FAQ
What is Atai Life Sciences N.V. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 51.37% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -133.42M, average is -139.00M and high is -77.82M.
What is Atai Life Sciences N.V. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 3229.79% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $250K, average is $250K and high is $250K.
What is Atai Life Sciences N.V. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 77.39% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$0.84, average is -$0.7 and high is $-0.49.
What is the best performing analyst?
In the last twelve months analysts have been covering Atai Life Sciences N.V. stock. The most successful analyst is Jason McCarthy.